Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

A systematic review of observational studies evaluating costs of adverse drug reactions.

Batel Marques F, Penedones A, Mendes D, Alves C.

Clinicoecon Outcomes Res. 2016 Aug 24;8:413-26. doi: 10.2147/CEOR.S115689. eCollection 2016. Review.

2.

Implementing the Use of Pharmacist Progress Notes in a Surgical ICU.

Sledge T, Lonardo N, Simons H, Shipley W.

Hosp Pharm. 2016 Jul;51(7):577-84. doi: 10.1310/hpj5107-577.

PMID:
27559191
3.

Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design.

Peddie D, Small SS, Badke K, Wickham ME, Bailey C, Chruscicki A, Ackerley C, Balka E, Hohl CM.

JMIR Res Protoc. 2016 Aug 18;5(3):e169. doi: 10.2196/resprot.5967.

4.

Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan.

Yasunaga D, Tasaka Y, Murakami S, Tanaka A, Tanaka M, Araki H.

J Pharm Policy Pract. 2016 Jul 19;10:2. doi: 10.1186/s40545-016-0073-7. eCollection 2017.

5.

Effects of non-severe acute kidney injury on clinical outcomes in critically ill patients.

Kellum JA, Murugan R.

Crit Care. 2016 Jun 4;20(1):159. doi: 10.1186/s13054-016-1295-4. No abstract available.

6.

Motor Activity in Aging: An Integrated Approach for Better Quality of Life.

Pratali L, Mastorci F, Vitiello N, Sironi A, Gastaldelli A, Gemignani A.

Int Sch Res Notices. 2014 Nov 24;2014:257248. doi: 10.1155/2014/257248. eCollection 2014. Review.

7.

Propofol-associated QTc prolongation.

Scalese MJ, Herring HR, Rathbun RC, Skrepnek GH, Ripley TL.

Ther Adv Drug Saf. 2016 Jun;7(3):68-78. doi: 10.1177/2042098616641354. Epub 2016 Apr 1.

8.

Association between Total Daily Doses with duration of hospitalization among readmitted patients in a multi-ethnic Asian population.

Teo V, Toh MR, Kwan YH, Raaj S, Tan SY, Tan JZ.

Saudi Pharm J. 2015 Sep;23(4):388-96. doi: 10.1016/j.jsps.2015.01.013. Epub 2015 Jan 10.

9.

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events.

Yu Y, Chen J, Li D, Wang L, Wang W, Liu H.

Sci Rep. 2016 Apr 22;6:24955. doi: 10.1038/srep24955.

10.

The Importance of Medication Errors Reporting in Improving the Quality of Clinical Care Services.

Elden NM, Ismail A.

Glob J Health Sci. 2015 Dec 18;8(8):54510. doi: 10.5539/gjhs.v8n8p243.

11.

Content and Usability Evaluation of Patient Oriented Drug-Drug Interaction Websites.

Adam TJ, Vang J.

AMIA Annu Symp Proc. 2015 Nov 5;2015:287-96. eCollection 2015.

12.

Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.

Miller AC, Polgreen LA, Cavanaugh JE, Polgreen PM.

Infect Control Hosp Epidemiol. 2016 Apr;37(4):404-10. doi: 10.1017/ice.2015.340. Epub 2016 Feb 9.

PMID:
26858126
13.

Variations in the Use of Perioperative Multimodal Analgesic Therapy.

Ladha KS, Patorno E, Huybrechts KF, Liu J, Rathmell JP, Bateman BT.

Anesthesiology. 2016 Apr;124(4):837-45. doi: 10.1097/ALN.0000000000001034.

PMID:
26835644
14.

An observational study of adult admissions to a medical ICU due to adverse drug events.

Jolivot PA, Pichereau C, Hindlet P, Hejblum G, Bigé N, Maury E, Guidet B, Fernandez C.

Ann Intensive Care. 2016 Dec;6(1):9. doi: 10.1186/s13613-016-0109-9. Epub 2016 Feb 2.

15.

Intravenous fluid prescribing: Improving prescribing practices and documentation in line with NICE CG174 guidance.

Sansom LT, Duggleby L.

BMJ Qual Improv Rep. 2014 Nov 3;3(1). pii: u205899.w2409. doi: 10.1136/bmjquality.u205899.w2409. eCollection 2014.

16.

Excess length of stay and economic consequences of adverse events in Dutch hospital patients.

Hoogervorst-Schilp J, Langelaan M, Spreeuwenberg P, de Bruijne MC, Wagner C.

BMC Health Serv Res. 2015 Dec 1;15:531. doi: 10.1186/s12913-015-1205-5.

17.
18.

Differences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug Reactions.

Ryu J, Lee H, Suh J, Yang M, Kang W, Kim E.

PLoS One. 2015 Nov 6;10(11):e0142418. doi: 10.1371/journal.pone.0142418. eCollection 2015.

19.

Adverse Drug Event Ontology: Gap Analysis for Clinical Surveillance Application.

Adam TJ, Wang J.

AMIA Jt Summits Transl Sci Proc. 2015 Mar 23;2015:16-20. eCollection 2015.

20.

Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

White KD, Chung WH, Hung SI, Mallal S, Phillips EJ.

J Allergy Clin Immunol. 2015 Aug;136(2):219-34; quiz 235. doi: 10.1016/j.jaci.2015.05.050. Review.

Items per page

Supplemental Content

Write to the Help Desk